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MRSA strains in most Asian region were ST239-MRSA-
SCCmecIII except for those from Korea and Japan which
were ST5-MRSA-SCCmecII. In Mainland China, our study
showed the most predominant types were ST239-SCCmecIII
and ST5-SCCmecII, which accounted for 75.5% and 17.0%,
respectively. The prevalence of pvl gene in all S. aureus
varied among different regions. Several studies indicated
that CA-MRSA had been emerging in Asia. A recent study
in China Hong Kong demonstrated 10.4% of S. aureus
isolates from patients with purulent skin and soft tissue
infections (SSTIs) were attributed to pvl-positive CA-MRSA.
The molecular characteristics of CA-MRSA showed different
patterns between regions, In Asia, strains in Singapore
was ST30-MRSA-SCCmecIV, in Hong Kong was ST30-MRSA-
SCCmecIV, ST59-MRSA-SCCmecV and ST8-MRSA-SCCmecIV,
in Taiwan was ST59-SCCmecIV, while in Korea, was ST72-
SCCmec type IV. Our ﬁnding showed two isolates of CA-MRSA
were found in Mainland China, one with ST88-SCCmec IV,
the other one with ST59-SCCmec IV. A study conducted by
ANSORP Study Group showed that Staphylococcus aureus
with reduced susceptibility to vancomycin existed in Asia.
The prevalence of hVISA was 4.3%, the highest in Japan
(8.2%). In our recent study we found the vancomycin MIC
was elevated. In Asia, notable high prevalence of MRSA
was observed. This is consistent with the establishment and
gradual spread within countries of distinct MRSA clones that
are highly resistant to common antibiotics, perhaps favored
by the relative geographic isolation of some contributors.
And the epidemiology patterns will surely complicate the
choice of therapy, and make it much harder.
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I-35 Extensively drug resistant tuberculosis (XDR-TB)
An overview
R.C. Read*. University of Shefﬁeld, UK
Extensively drug resistant tuberculosis (XDR-TB) is deﬁned
as tuberculosis caused by a Mycobacterium tuberculosis
strain which is resistant to Rifampicin and isoniazid
(i.e. multidrug-resistant tuberculosis MDRTB), but in
addition is resistant to a ﬂuoroquinolone, plus at least
one injectable second-line anti-tuberculous drug (i.e. one
of amikacin, kanamycin and/or capreomycin). The World
Health Organisation has established sentinel reference
laboratories throughout the world and XDR-TB strains
are being identiﬁed in all continents with a worldwide
prevalence in the region of 7% amongst MDRTB strains.
Recent studies in Southern Africa have demonstrated the
very high mortality associated with XDR-TB especially in
patients co-infected with human immunodeﬁciency virus.
Therapeutic options are extremely limited. The emergence
of XDR-TB is a reﬂection of failure to manage compliance of
tuberculosis chemotherapy coupled with failure to follow
international therapeutic guidelines. Managing cases is
exceptionally complex and requires specialised facilities
and therapeutics. Controlling the emergence of XDR-TB
will require a concerted and urgent global public health
response, particularly in developing countries with limited
resources and those countries with high rates of sero-
prevalence of HIV.
I-36 Latent infection of M. tuberculosis in China
W.H. Zhang*. Department of Infectious diseases, Huashan
Hospital, Fudan University, Shanghai, 200040, China
Background and Objectives: Tuberculosis (TB) is the second
leading cause of death worldwide, killing around 1.8 million
persons annually. Despite well-implemented DOT in China,
cases of active tuberculosis keep increasing. According to
the report from Chinese government, annual new pulmonary
TB cases increased by 29% from 0.97 million in year 2004
to 1.25 million in year 2005. However, the disease burden
of latent infection of M. tb and its contribution to new
cases of tuberculosis are still unclear in China and there
has been no formal reports describing the incidence of
latent tuberculosis infection (LTBI) conversion to active TB.
Meanwhile, The immune mechanisms for LTBI conversion to
active TB remain poorly characterized. The objective of this
study is to describe the prevalence of latent tuberculosis
infection (LTBI) in high risk populations in China and explore
the mechanisms of conversion to active TB from LTBI.
Methods and Results: We have designed a cross-section
study including 3 groups of persons at high risk, including
house contacts to TB cases and HIV positive patients.
Using the rapid ELISPOT assay, we enumerated T-cells
speciﬁc for ESAT-6 and CFP-10 in blood samples from
194 household contacts of these tuberculosis cases and
100 HIV positive cases. Intracellular cytokine staining (ICS)
were employed to detect the changes of numbers and
function of T lymphocytes in all subpopulations. The results
showed that a 48.96% prevalence of latent M. tuberculosis
infection in China in high risk populations who have intimate
contact with patients with active tuberculosis. Meanwhile
the prevalence of latent M. tuberculosis infection in HIV
positive cases is up to 59%. The percentage of CD3+CD4+
and CD3+CD8+ cells and their subsets in CD3+ T-cells in
peripheral blood is decreased dramatically in HIV positive
cases with infection or latent infection of M. tuberculosis.
Conclusions: 1. ELISPOT assay is a more sensitive assay
for detection of active pulmonary TB without treatment
than conventional tools. It is more speciﬁc, and possibly
more sensitive, than PPD-based methods of detecting
latent M. tuberculosis infection in China. 2. The disease
burden of latent infection of M. tuberculosis is heavy in
China and whether it is of high priority to treat LTBI
in China to boost the decline of TB pandemics under
the DOTS program remains to be determined. 3. The
results also shows CD3+CD4+, CD3+CD8+ and Vg2Vd2+ T-cells
may all contribute to the immune protection against the
mycobacterial infection and is highly associated with the
conversion from latent infection to active infection of
M. tuberculosis.
I-37 Epidemiology of Mycobacterium tuberculosis
genotypes in different ethnic and age populations
in Taiwan
I.J. Su*, H.Y. Dou. Division of Clinical Research, National
Health Research Institutes, Tainan, Taiwan
Aims: The distribution of human Mycobacterium
tuberculosis (MTB) genotypes is closely associated with
geography, ethnicity, age and host factors. This study is
designed to study the molecular epidemiology of MTB in
Taiwan with emphasis on the ethnicity and migratory history
(Part I). The distribution of MTB genotypes in metropolitan
Taipei city was further analyzed with speciﬁc emphasis on
the clustering and age association (Part II).
Methods and Results: Part I study: Three groups of 208
patients with tuberculosis in Taiwan were sampled to
test this observation: (1) 41 aborigines of Austronesian
ethnicity, who have been inhabiting in Taiwan for more
than 500 years; (2) 58 veterans of Han Chinese origin,
who moved as the ﬁrst generation from Mainland China to
Taiwan 55 60 years ago; and (3) 109 patients representing
the general Taiwanese population of Han Chinese whose
ancestors migrated to Taiwan around 200 400 years ago. A
total of 208 MTB isolates, one per patient, were analyzed by
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spoligotyping and mycobaterial interspersed repetitive unit
(MIRU) typing. Beijing ancient strains and Harrlem strains
predominated among aborigines, while Beijing modern
strains were common among veterans and the general
population. All Beijing strains were further analyzed by
typing the NTF loci and RD deletion. Results suggest
a chronological trend among Beijing isolates from the
three groups: isolates from the aborigines had signatures
compatible with ancient lineages, and those from veterans
and the general population were more contemporary. Our
data indicate that the distribution of MTB genotypes/strains
in Taiwan is associated with different populations whose
migratory activities occurred between 55 and 500 years
ago. These results suggest that transmission of MTB may
have been relatively restricted to close contacts.
Part II study: A total of 356 MTB isolates were analyzed
for the genotypes of MTB in metropolitan city. Major
spoligotypes found were Beijing lineages (52.5%), followed
by Haarlem lineages (13.5%) and EAI plus EAI-like lineages
(11%). When MIRU-VNTR was employed, 140 patterns were
identiﬁed, including 36 clusters by 252 isolates and 104
unique patterns, and the largest cluster comprised 95
isolates from the Beijing family. The combination of
spoligotyping and MIRU-VNTR revealed that 236 (67%) of
the 356 isolates were clustered in 43 genotypes, and thus
the proportion of TB infection that can be considered due
to the recent transmission is estimated (236 43)/356 = 54%.
Patients infected with Beijing strains were younger than
those with other strains. Moreover, infected persons younger
than 25 years had Beijing modern stain, suggesting a possible
recent spread in the young population by this family of TB
strain in Taipei.
Conclusion: The distribution of MTB in Taiwan is closely
associated with the ethnicity and migratory population
at different historical periods. The high clustering of
MTB isolates and the high prevalence of Beijing family
strains in young persons strongly indicate that a stringent
control policy should be taken in Taiwan, particularly in
metropolitan city.
I-38 Recent advances in the diagnosis of TB
G. Roscigno*. Foundation for Innovative New Diagnostics,
Geneva, Switzerland
Microscopy is still the backbone and benchmark of
laboratory diagnostics in TB, but it is well recognized
that better technical approaches are urgently needed to
overcome limitations in test sensitivity, time to result and
ease of use. The ultimate alternative products are expected
to provide rapid testing in primary care settings. To this end
a number of opportunities are being followed up, ranging
from identiﬁcation of novel biomarkers for various stages
of disease to the development of enabling technologies
suited for implementation in the different sectors of the
health care system in developing countries, i.e., from the
reference laboratory down to the health post in rural areas
where the biggest gaps exist.
It has become widely accepted that resolution of open
issues in TB diagnostics can only be achieved by systematic
and novel research approaches. Among these are the
seroproﬁling of the whole M. tuberculosis proteome using
antigen arrays, discovery of marker molecules in sputum
and urine employing most advanced mass spectrometry.
Both development programs are progressing at fast pace.
In addition, two rapid molecular detection systems have
been developed and are close to entering international
evaluation studies: an assay developed by Eiken Chemicals
represents the ﬁrst manual molecular TB test emplyoing
rapid DNA ampliﬁcation based on LAMP technology whereas
the GeneXpert platform from Cepheid, Inc. provides fully
automated point of care Mtb DNA detection by rtPCR at
an ultrasensitive level. These technology approaches are
considered breakthrough diagnostics that for the ﬁrst time
will enable robust Mtb nucleic acid detection in fast and
affordable formats.
The recent introduction and WHO endorsement of
technologies such as liquid culture, rapid speciation and
molecular DST demonstrate that our current approaches
are effective and already show their impact. These
achievements will be furter complemented by the
introduction of iLED, a low cost ﬂuorescence microscope
that will signiﬁcantly incraese sensitivity of sputum smear
analysis.
However, it is also clear that those achievements all
based on private-public-partnerships were only made
possible by implementing a strong industry-type quality and
project management system as an ultimate prerequisite for
successful product development. Using available, leading
edge tools in biomarker discovery, detection technology
and project management, we are now in an excellent
position to further narrow and even close current gaps
in TB diagnostics.
I-39 Molecular diagnosis of tuberculosis
H.Y. Lee1, S.N. Cho2 *. 1Department of Biomedical
Laboratory Science, College of Health Sciences, Yonsei
University, Kangwon 220 710; 2Department of Microbiology,
Yonsei University College of Medicine, Seoul 120 752,
Republic of Korea
Molecular tests have brought a signiﬁcant impact on
laboratory diagnosis of tuberculosis (TB) from simple
detection of Mycobacterium tuberculosis from clinical
specimens to rapid detection of MDR/XDR-TB. As an effort
to implement those tests to clinical mycobacteriology
laboratories, we also have been working on developing
and evaluation various molecular techniques using clinical
samples and mycobacterial cultures.
Firstly, we tried to detect M. tuberculosis-speciﬁc DNA
in sputum samples by polymerase chain reaction (PCR),
and target DNAs were IS6110, region of deletions (RDs),
and the rpoB gene, etc. Since the proportion of non-
tuberculous mycobacteria (NTM) has increased in many
countries, we also developed molecular tests, in which
primer sets detecting both M. tuberculosis and NTMs were
included and evaluated them using sputum samples and
mycobacterial cultures from both solid and liquid culture
systems.
Secondly, we developed a series of molecular tests
for identiﬁcation of Mycobacterium species. Initially, we
employed a PCR-restriction enzyme analysis (PRA) targeting
a polymorphic region of the rpoB gene. Using the PRA, we
were able to differentiate more than 50 Mycobacterium
species. Mycobacterium species-speciﬁc probes were then
designed and used in a dot-blot assay and a reverse-blot
hybridization assay (RBHA). At least 13 Mycobacterium
species, covering more than 95% of mycobacteria from
clinical samples in Korea, were successfully identiﬁed either
by dot-blot or by RBHA.
Thirdly, we explored the dot-blot assay and RBHA to detect
mutations of genes associated with resistance to anti-TB
drugs, both the ﬁrst and second line drugs. As appeared in
numerous literatures, we found the in-house made RBHA
is working properly for detecting mutations at katG, inhA,
and ahpC genes for resistance to INH, at the rpoB gene
to RIF, at the rrs and rpsL genes to SM, KAN, AMK, and
CAP, and the gyrA gene to OFX. Although there is still a
substantial portion of M. tuberculosis isolates which do not
have mutations at these genes, RBHA has been useful in
reducing turn-around time substantially for rapid detection
